ALS patients press FDA for quick access to controversial biotech drug – The Washington Post

This is a good even handed report about Genervon efforts including social media to win fast track FDA approval for GM604 for ALS. I’ve been pushing for faster review but Genervon hasn’t published any real data, just a public relations campaign which falls short of science. They’ve exasperated their clinical investigators at Columbia and Massachusetts General.

It wouldn’t take much for me to want to try it. But it will take something more than a prayer.

http://www.washingtonpost.com/national/health-science/als-patients-press-fda-for-quick-access-to-controversial-biotech-drug/2015/04/03/fb954618-d220-11e4-a62f-ee745911a4ff_story.html

3 thoughts on “ALS patients press FDA for quick access to controversial biotech drug – The Washington Post

  1. Hi Mike – I would trust your judgment and experience in this case, and am interested in knowing what you think. I get a little whiff of concern about the Kohs – maybe they are excellent scientists and spiritually inspired, but there are so many instances where blurred lines between works of faith, which can be powerful, and scientific evidence of healing – well, you get the picture. This part of NY State was called the “Burned-over District” because of all the religious/medical cure movements that swept across the area. I am for anything that provides people with comfort and hope, whether it’s spiritual, medical: mainstream, alternative/complementary or even “fringe,” but I hate to see people get exploited for profit, or simply misled. Whew – tough one my friend, or is it? Let me know your thoughts.

    Reply

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s